GHSI Guardion Health Sciences

Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements, medical foods, and medical devices, announced today that Chief Executive Officer Bret Scholtes will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021.

Mr. Scholtes will deliver his corporate presentation on June 9 at 12:30pm ET, Track 2.

Investors can register to watch the presentation re.

Investors interested in scheduling a meeting with management should contact .

About Guardion Health Sciences, Inc.

Guardion Health Sciences, Inc. (NASDAQ: GHSI), is a clinical nutrition and diagnostics company. Guardion offers a portfolio of science-based, clinically supported nutrition, supplements, medical foods, and diagnostic products that support healthcare professionals, their patients, and consumers in achieving health goals. Guardion’s commercial and developmental initiatives are supported by equally impressive scientific and medical advisory boards, led by seasoned business executives and physicians with many years of experience. This combination of expertise and scientific knowledge forms the foundation of Guardion’s growing position within the eye care industry and the clinical nutrition marketplace. Information and risk factors with respect to Guardion and its business, including its ability to successfully develop and commercialize its proprietary products and technologies, may be obtained in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”) at

Investor Relations Contact:

CORE IR

Scott Arnold

516-222-2560

Media Relations Contact:

Jules Abraham

Director of Public Relations

CORE IR

917-885-7378



EN
02/06/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Guardion Health Sciences

 PRESS RELEASE

Guardion Health Sciences Announces Financial Results for the Three Mon...

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023 Viactiv® Product Line Total Revenue Increased Approximately 6% for the Six Months Ended June 30, 2023, as Compared to the Six Months Ended June 30, 2022; Robust Growth in Amazon Sales Channel Demonstrates Positive Results of Company’s Focus on eCommerce Initiatives HOUSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported produc...

 PRESS RELEASE

Guardion Health Sciences Announces Appointment of Former Neutrogena an...

Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer Former President and Chief Executive Officer Bret Scholtes Resigning to Pursue Other Business Opportunities HOUSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced tha...

 PRESS RELEASE

Guardion Health Sciences Announces Financial Results for the Quarter E...

Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023 Viactiv® Product Line Total Revenue Increased approximately 37% for the Quarter Ended March 31, 2023 as compared to the Quarter Ended March 31, 2022 HOUSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial ...

 PRESS RELEASE

Guardion Health Sciences Announces Financial Results for the Year Ende...

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022 Viactiv® Product Line Generated Net Revenues of approximately $10.6 Million or 96% of Net Revenues for the Year Ended December 31, 2022 HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial results for...

 PRESS RELEASE

Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor t...

Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value Alantra, LLC is an experienced and successful international healthcare investment banking firm HOUSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, has retained Alantra, LLC (“Alant...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch